UPDATED 20.02.2014 13:04

Organised cervical cancer screening programme in Finland in the invitation year 2006. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 427 municipalities (out of 431).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 174084 1502 0.86 7 0.00 6 0.00 46 0.03 167 0.10 199 0.11 177 0.10 900 0.52
I 163257 5 0.00 - - - - - - - - 1 0.00 - - 4 0.00
II 9332 194 0.11 - - - - - - 3 0.00 8 0.00 23 0.01 160 0.09
III 1182 1177 0.68 3 0.00 4 0.00 21 0.01 109 0.06 170 0.10 149 0.09 721 0.41
IV 122 122 0.07 4 0.00 1 0.00 22 0.01 55 0.03 20 0.01 5 0.00 15 0.01
V 4 4 0.00 - - 1 0.00 3 0.00 - - - - - - - -
Inadequate 116 - - - - - - - - - - - - - - - -
Unknown 71 - - - - - - - - - - - - - - - -
HPV test 16771 302 1.80 4 0.02 1 0.01 10 0.06 26 0.16 53 0.32 43 0.26 165 0.98
Negative1 14971 6 0.04 - - - - - - - - - - 1 0.01 5 0.03
Positive2 1800 296 1.76 4 0.02 1 0.01 10 0.06 26 0.16 53 0.32 42 0.25 160 0.95
Total 190855 1804 0.95 11 0.01 7 0.00 56 0.03 193 0.10 252 0.13 220 0.12 1065 0.56

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.